"Alli tablets are designed to target fat in your digestive system. For every 2lb you lose from dieting alone, adding Alli can help you lose 1lb more."
Alli tablets stop about a quarter of the fat in your meals from being absorbed.

 


Is alli suitable for the elderly?

 alli is indicated for use by overweight people 18 years of age or older, including older adults. If you have specific issues or health concerns, please check with your pharmacist or doctor.

I’ve got diabetes. Can I still take alli?

Yes, you can take alli if you have diabetes. If you are taking a medicine for diabetes, please tell your doctor before you start to take alli. Your doctor may need to adjust your anti-diabetic medicine if you lose some weight. This is because losing weight can improve your blood sugar levels.

I’ve got high blood pressure. Can I still take alli?

Yes, you can take alli if you have high blood pressure. Please tell your doctor or pharmacist that you are using alli if you are using a medicine for high blood pressure. Your doctor may need to adjust the dose of this medicine if you lose some weight. This is because losing weight can improve your blood pressure.

I’ve got high cholesterol. Can I still take alli?

Yes, you can take alli if you have high cholesterol. Please tell your doctor or pharmacist that you are taking alli if you are using a medicine for high cholesterol. Your doctor may need to adjust the dose of this medicine if you lose some weight. This is because losing weight can improve your cholesterol levels

Can I take alli if I suffer from epilepsy?

Talk to your doctor before taking alli if you are taking a medicine for epilepsy as any changes in the frequency and severity of your convulsions should be discussed with your doctor.

Can I take alli if I have a thyroid problem?

Yes but speak to your doctor before you start taking alli. It may be necessary to adjust the dose of your thyroid medicine (levothyroxine) and take it at different times of the day.

What should a woman do if she becomes pregnant while taking alli?

Women who are pregnant or breast-feeding must not take alli. If a woman discovers that she is pregnant while taking alli, she should stop taking the capsules and talk to her doctor.

 

GSK statement regarding the Watchdog report into the online sale of alli

Following the Watchdog report on Thursday 13th May, We want to reassure you of the safety profile of alli, which contains orlistat, the most extensively studied weight loss medicine available. alli is for adults (aged 18 or over) with a BMI of 28 or more and should be used in conjunction with a reduced calorie, lower-fat diet. We did not apply for a licence for under 18 year olds because the treatment of obesity in under 18s is very challenging and requires the specialist support of doctors and other healthcare professionals. Importantly in terms of safety, studies in adolescents have shown that the safety profile of orlistat is similar to that in adults. There is no evidence to support claims that alli reduces vitamin levels in adolescents to a degree that would cause any harm.

There are no additional safety concerns for people with eating disorders. If people with eating disorders were to obtain alli, due to the way that this weight loss aid works, it simply does not provide people with either the purgative action or the rapid weight reduction they may seek. People with eating disorders should not buy alli or any other weight loss products but seek the help and support they need from their GP or valuable organisations such as beat.

Obesity and overweight are a major concern and many people need help; online pharmacy provides people with discreet access to advice, care and valuable products such as alli. Stopping online pharmacy sales could prevent people from gaining access to the healthcare products they may need. It is the responsibility of the retailers to sell alli in accordance with the licence and we will be reviewing with online pharmacies any additional measures that could be put in place to tighten up the online process. 

GSK update

In light of the U.S Food and Drug Administration (FDA) review of orlistat (alli) in relation to liver injury please find below a statement from GlaxoSmithKline Consumer Healthcare (GSK).

GSK is updating the alli (orlistat 60 mg) product label in the United States to inform people using alli that if they experience certain symptoms that have been associated with rare instances of severe liver injury to stop using the product and speak with their doctor.

The European approved product label for alli already carries similar information.

This precautionary action follows the FDA’s review of reports of liver injury in a limited number of people using orlistat, the active ingredient in alli, that were collected over a span of more than 10 years. The update is being implemented in conjunction with Roche, the manufacturer of the prescription dose of orlistat.

The FDA announcement states that: At this time, a cause and effect relationship of severe liver injury with orlistat use has not been established.

Because of the seriousness of severe liver injury, FDA has added information about reported cases of severe liver injury to the label of the prescription dose of orlistat and alli, to educate the public about the signs and symptoms of liver injury and the need to see a physician promptly should they occur.

Some patients in the reported cases also used other drugs or had other conditions that may have contributed to the development of severe liver injury. Severe liver injury can occur in people not taking drugs and without a distinct cause